Advertisement

Are There Differences in Hair Mineral Concentrations Between Metabolically Healthy and Unhealthy Obese Adults?

  • Yun-Ah Lee
  • Se-Hong Kim
  • Ha-Na Kim
  • Sang-Wook SongEmail author
Article
  • 21 Downloads

Abstract

Obesity is a risk factor for metabolic syndrome, dyslipidemia, hypertension, insulin resistance, type 2 diabetes mellitus, and cardiovascular disease. However, obesity is not a homogenous state and not all subjects in an obese population are at an increased risk for metabolic abnormalities. Thus, obesity types can be subdivided into metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) according to metabolic status. Body minerals are important and are involved in various metabolic processes that may be related to obesity. Thus, this study determined whether hair mineral concentrations differ between MHO and MUO adults. The associations between metabolic risk factors and hair mineral concentrations were analyzed in 141 obese Korean adults (62 MHO subjects and 79 MUO subjects). The MUO subjects showed significantly higher triglyceride levels, systolic blood pressure, waist circumference and body mass index, lower high-density lipoprotein cholesterol levels, and greater insulin resistance as reflected by the homeostasis model assessment-insulin resistance (HOMA-IR) index compared with MHO subjects. No significant differences in hair mineral concentrations were detected between MHO and MUO adults. Hair iron and cobalt concentrations were significantly negatively correlated with blood pressure in subjects with MHO. In addition, hair zinc concentration was associated with decreased systolic blood pressure. The results of this study suggest that mineral status in obese adults may play a role in metabolic abnormalities. Further studies with a larger number of subjects are warranted to identify the nature of the relationship between hair mineral status and metabolic risk in MHO and MUO subjects.

Keywords

Obesity Metabolic syndrome Hair minerals Blood pressure 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

For this type of study, formal consent is not required. The study protocol was approved by the Catholic University of Korea St. Vincent’s Hospital Institutional Review Board (IRB approval number: VC18RESI0177).

References

  1. 1.
    Bastien M, Poirier P, Lemieux I, Despres JP (2014) Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 56:369–381CrossRefGoogle Scholar
  2. 2.
    Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113:898–918CrossRefGoogle Scholar
  3. 3.
    Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91:2906–2912CrossRefGoogle Scholar
  4. 4.
    Durward CM, Hartman TJ, Nickols-Richardson SM (2012) All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes 2012:460321CrossRefGoogle Scholar
  5. 5.
    Hong HC, Lee JS, Choi HY, Yang SJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2013) Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey. Metabolism 62:1305–1312CrossRefGoogle Scholar
  6. 6.
    Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Haring HU (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609–1616CrossRefGoogle Scholar
  7. 7.
    Poli VFS, Sanches RB, Moraes ADS, Fidalgo JPN, Nascimento MA, Bresciani P, Andrade-Silva SG, Cipullo MAT, Clemente JC, Caranti DA (2017) The excessive caloric intake and micronutrient deficiencies related to obesity after a long-term interdisciplinary therapy. Nutrition 38:113–119CrossRefGoogle Scholar
  8. 8.
    Garcia OP, Long KZ, Rosado JL (2009) Impact of micronutrient deficiencies on obesity. Nutr Rev 67:559–572CrossRefGoogle Scholar
  9. 9.
    Via M (2012) The malnutrition of obesity: micronutrient deficiencies that promote diabetes. ISRN Endocrinol 2012:103472CrossRefGoogle Scholar
  10. 10.
    Fatani SH, Saleh SA, Adly HM, Abdulkhaliq AA (2016) Trace element alterations in the hair of diabetic and obese women. Biol Trace Elem Res 174:32–39CrossRefGoogle Scholar
  11. 11.
    Skalnaya MG, Skalny AV, Grabeklis AR, Serebryansky EP, Demidov VA, Tinkov AA (2018) Hair trace elements in overweight and obese adults in association with metabolic parameters. Biol Trace Elem Res 186:12–20CrossRefGoogle Scholar
  12. 12.
    Suliburska J, Bogdanski P, Pupek-Musialik D, Krejpcio Z (2011) Dietary intake and serum and hair concentrations of minerals and their relationship with serum lipids and glucose levels in hypertensive and obese patients with insulin resistance. Biol Trace Elem Res 139:137–150CrossRefGoogle Scholar
  13. 13.
    Krol E, Bogdanski P, Suliburska J, Krejpcio Z (2018) The relationship between dietary, serum and hair levels of minerals (Fe, Zn, Cu) and glucose metabolism indices in obese type 2 diabetic patients. Biol Trace Elem ResGoogle Scholar
  14. 14.
    Miao X, Sun W, Fu Y, Miao L, Cai L (2013) Zinc homeostasis in the metabolic syndrome and diabetes. Front Med 7:31–52CrossRefGoogle Scholar
  15. 15.
    Tang X, Shay NF (2001) Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr 131:1414–1420CrossRefGoogle Scholar
  16. 16.
    Klevay LM, Bistrian BR, Fleming CR, Neumann CG (1987) Hair analysis in clinical and experimental medicine. Am J Clin Nutr 46:233–236CrossRefGoogle Scholar
  17. 17.
    Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752CrossRefGoogle Scholar
  18. 18.
    Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75:72–80CrossRefGoogle Scholar
  19. 19.
    Jung CH, Lee MJ, Hwang JY, Jang JE, Leem J, Yang DH, Kang JW, Kim EH, Park JY, Kim HK, Lee WJ (2014) Association of metabolically healthy obesity with subclinical coronary atherosclerosis in a Korean population. Obesity (Silver Spring) 22:2613–2620CrossRefGoogle Scholar
  20. 20.
    Medical Systems; Clinical Analyzer, Laboratory Automatic Systems, Service & Support. https://www.hitachi-hightech.com/global/science/products/medical-systems. Accessed 15 Oct 2018
  21. 21.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefGoogle Scholar
  22. 22.
    Kim HN, Kim SH, Eun YM, Song SW (2018) Effects of zinc, magnesium, and chromium supplementation on cardiometabolic risk in adults with metabolic syndrome: a double-blind, placebo-controlled randomised trial. J Trace Elem Med Biol 48:166–171CrossRefGoogle Scholar
  23. 23.
    Trace Elements Laboratory profiles. https://www.traceelements.com/LabServices/LabProfiles.aspx. Accessed 15 Oct 2018
  24. 24.
    Choi WS, Kim SH, Chung JH (2014) Relationships of hair mineral concentrations with insulin resistance in metabolic syndrome. Biol Trace Elem Res 158:323–329CrossRefGoogle Scholar
  25. 25.
    Wang Y, Wei J, Zeng C, Yang T, Li H, Cui Y, Xie D, Xu B, Liu Z, Li J, Jiang S, Lei G (2018) Association between serum magnesium concentration and metabolic syndrome, diabetes, hypertension and hyperuricaemia in knee osteoarthritis: a cross-sectional study in Hunan Province, China. BMJ Open 8:e019159CrossRefGoogle Scholar
  26. 26.
    Maier JA (2003) Low magnesium and atherosclerosis: an evidence-based link. Mol Asp Med 24:137–146CrossRefGoogle Scholar
  27. 27.
    Houston M (2011) The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich) 13:843–847CrossRefGoogle Scholar
  28. 28.
    Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M (2003) Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 27:416–418CrossRefGoogle Scholar
  29. 29.
    Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M (2004) Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 114:104–108CrossRefGoogle Scholar
  30. 30.
    Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803–811CrossRefGoogle Scholar
  31. 31.
    Fields M, Lewis CG (1999) Level of dietary iron, not type of dietary fat, is hyperlipidemic in copper-deficient rats. J Am Coll Nutr 18:353–357CrossRefGoogle Scholar
  32. 32.
    Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, Shoumin Z (1998) Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 17:564–570CrossRefGoogle Scholar
  33. 33.
    Bergomi M, Rovesti S, Vinceti M, Vivoli R, Caselgrandi E, Vivoli G (1997) Zinc and copper status and blood pressure. J Trace Elem Med Biol 11:166–169CrossRefGoogle Scholar
  34. 34.
    Kim J (2013) Dietary zinc intake is inversely associated with systolic blood pressure in young obese women. Nutr Res Pract 7:380–384CrossRefGoogle Scholar
  35. 35.
    Canatan H, Bakan I, Akbulut M, Halifeoglu I, Cikim G, Baydas G, Kilic N (2004) Relationship among levels of leptin and zinc, copper, and zinc/copper ratio in plasma of patients with essential hypertension and healthy normotensive subjects. Biol Trace Elem Res 100:117–123CrossRefGoogle Scholar
  36. 36.
    Chiplonkar SA, Agte VV, Tarwadi KV, Paknikar KM, Diwate UP (2004) Micronutrient deficiencies as predisposing factors for hypertension in lacto-vegetarian Indian adults. J Am Coll Nutr 23:239–247CrossRefGoogle Scholar
  37. 37.
    Liang C, Wang J, Xia X, Wang Q, Li Z, Tao R, Tao Y, Xiang H, Tong S, Tao F (2018) Serum cobalt status during pregnancy and the risks of pregnancy-induced hypertension syndrome: a prospective birth cohort study. J Trace Elem Med Biol 46:39–45CrossRefGoogle Scholar
  38. 38.
    Goncalves CG, Glade MJ, Meguid MM (2016) Metabolically healthy obese individuals: key protective factors. Nutrition 32:14–20CrossRefGoogle Scholar
  39. 39.
    Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168:1617–1624CrossRefGoogle Scholar
  40. 40.
    Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, Adams RJ (2013) Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 36:2388–2394CrossRefGoogle Scholar
  41. 41.
    Arner P (2001) Regional differences in protein production by human adipose tissue. Biochem Soc Trans 29:72–75CrossRefGoogle Scholar
  42. 42.
    Kramer CK, Zinman B, Retnakaran R (2013) Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med 159:758–769CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Family Medicine, St. Vincent’s Hospital, College of MedicineThe Catholic University of KoreaSeoulRepublic of Korea

Personalised recommendations